Takumi Fujiwara

Tsu, 5148507, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Dual drivers of polypharmacy in people with HIV: Quantifying the independent associations of aging and long-term antiretroviral therapy.

Dual drivers of polypharmacy in people with HIV: Quantifying the independent associations of aging and long-term antiretroviral therapy.

Journal: HIV medicine

Published: July 29, 2025

Prognostic impact of genomically matched therapy for solid cancers using real-world data from a provincial hospital in Japan.

Prognostic impact of genomically matched therapy for solid cancers using real-world data from a provincial hospital in Japan.

Journal: International journal of clinical oncology

Published: July 24, 2025

A case of neuroendocrine carcinoma of the urachal cancer with comprehensive genomic profiling results.

A case of neuroendocrine carcinoma of the urachal cancer with comprehensive genomic profiling results.

Journal: International cancer conference journal

Published: July 19, 2025

Comprehensive Genomic Profiling Tests for Japanese Patients with Metastatic Castration-Resistant Prostate Cancer : A Single-Institution Experience

Comprehensive Genomic Profiling Tests for Japanese Patients with Metastatic Castration-Resistant Prostate Cancer : A Single-Institution Experience

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: July 06, 2025

Case report: Severe arrhythmogenic cardiomyopathy in a young girl with compound heterozygous DSG2 and MYBPC3 variants with a 6-year follow-up.

Case report: Severe arrhythmogenic cardiomyopathy in a young girl with compound heterozygous DSG2 and MYBPC3 variants with a 6-year follow-up.

Journal: Frontiers in genetics

Published: December 15, 2024

Transforming Lung Cancer Management: A Promising Case Study of Immune Checkpoint Inhibitor Success Following a Multidisciplinary Approach.

Transforming Lung Cancer Management: A Promising Case Study of Immune Checkpoint Inhibitor Success Following a Multidisciplinary Approach.

Journal: Diagnostics (Basel, Switzerland)

Published: August 30, 2024

When and how should next-generation sequencing and comprehensive genomic profiling assays be performed?

When and how should next-generation sequencing and comprehensive genomic profiling assays be performed?

Journal: Cancer science

Published: April 19, 2024

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).

Journal: Targeted oncology

Published: March 04, 2024

Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.

Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.

Journal: Cancer medicine

Published: November 02, 2023

Effect of the Japanese herbal medicine Hochuekkito for systemic inflammation, prognostic nutrition index, and body composition status in patients with gastrointestinal cancer.

Effect of the Japanese herbal medicine Hochuekkito for systemic inflammation, prognostic nutrition index, and body composition status in patients with gastrointestinal cancer.

Journal: Clinical nutrition ESPEN

Published: April 06, 2023

Next-generation sequencing clarified why first-line treatment with osimertinib was ineffective in an autopsied case of EGFR-mutated lung squamous cell carcinoma.

Next-generation sequencing clarified why first-line treatment with osimertinib was ineffective in an autopsied case of EGFR-mutated lung squamous cell carcinoma.

Journal: Thoracic cancer

Published: December 10, 2022

Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy.

Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy.

Journal: Cancers

Published: July 23, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026